scorecardresearch
Add as a preferred source on Google
Saturday, October 25, 2025
TopicPharma

Topic: Pharma

US lawsuit settlement puts spotlight back on ranitidine. India still undecided on ‘cancer-risk’ drug

Ranitidine still sold as popular heartburn medicine in India despite being banned or suspended in US, Europe & Australia. It was dropped from essential medicines list last year.

‘Diabetes capital’ India slated to get world’s 1st once-a-week insulin ‘by 2025’

Danish pharma giant Novo Nordisk's Icodec could be game-changer for diabetics. The drug is nearing regulatory approval in US & EU, says company.

Govt sets deadline for pharma MSMEs to adopt good manufacturing practices. ‘Follow or be penalised’

Health minister concedes implementation of Schedule M of Drugs and Cosmetics Act has been poor. Timeline for adherence to norms for good manufacturing practices began on 1 August.

Special inspection drive by drug controllers in 20 states, 26 pharma companies show-caused

The Drug Controller General of India (DCGI) has carried out nationwide inspections following a spate of incidents where drugs imported from India were found to be substandard or spurious.

Meth manufacturing drugs worth Rs 390 cr seized in Mizoram, probe suggests trafficking to Myanmar

Assam Rifles and the Mizoram customs department seized 39,04,000 triprolidine and pseudoephedrine tablets which act as precursors in manufacturing of addictive crystal methamphetamine.

India-made ‘artificial tears’ linked to superbug outbreak in US. FDA restricts imports

Chennai-based Global Pharma's eye drops were linked to drug-resistant bacteria outbreak, which 'infected 55 & led to the death of one person'.

Using ‘4IR’ tech to beat global challenges — why 4 Indian firms are on WEF’s ‘lighthouses’ list

Cipla, Dr Reddy’s Lab, Mondelez & Unilever lauded for transition to fourth industrial revolution using advanced technologies despite global challenges like Ukraine war & Covid.

Molnupiravir helps in faster recovery of mild Covid patients, says Hetero after phase 3 trials

Hyderabad-based pharma company, Hetero, announced promising interim results of phase 3 trials and has approached DCGI for emergency use authorisation for the drug in India.

Understand India’s pharma needs but domestic consumption priority: Biden administration

The issue received attention after Adar Poonawalla, CEO of the Serum Institute of India requested US President to lift the embargo of raw material exports to ramp up vaccination.

China’s Gland Pharma launches India’s biggest pharmaceutical IPO

The company and existing holders including Fosun Pharma Industrial Pte. are selling as many as 43.2 million shares for anywhere between Rs 1,490-1,500 each.

On Camera

Piyush Pandey brought the language of small towns into ad agency corridors: Prasoon Joshi

Piyush was about celebration—of life, of people, of stories. He believed that what we create can shape popular culture, can make people feel proud of who they are.

US sanctions Rosneft & Lukoil: What we know of 2 oil giants that produce half of Russia’s crude

Rosneft, the Russian state-owned oil behemoth, has large interests in India. Reliance has a contract to purchase 500,000 barrels of crude per day from the firm.

From battle of wits and daring air strikes to artillery fury, new details emerge of Operation Sindoor

Fresh details of operation conducted by IAF, Army have come out in gazette notification giving citations of those who were awarded Vir Chakra for their bravery.

CJI, IPS, IAS & Homebound: A wake-up call 75 years in the making

Education, reservations, govt jobs are meant to bring equality and dignity. That we are a long way from that is evident in the shoe thrown at the CJI and the suicide of Haryana IPS officer. The film Homebound has a lesson too.